Here is a thorough synthesis of what the research shows on jackfruit and gut/GI cancers:
Jackfruit and Gut Cancer: What the Research Shows
The relationship is primarily protective and anti-tumour - multiple bioactive compounds in jackfruit (fruit, seed, wood, leaves) have shown anti-cancer activity against colorectal and other gut cancers in lab and animal studies. There is no evidence that jackfruit causes or promotes gut cancer.
Key Bioactive Compounds and Their Mechanisms
1. Jacalin (Jackfruit Seed Lectin)
This is the most studied compound. Jacalin is a carbohydrate-binding protein (lectin) isolated from jackfruit seeds. A
2023 review in Anti-Cancer Drugs found jacalin shows
potent anticancer activity against colon cancer, blood cancer, and breast cancer. Mechanisms include:
- Targeting cancer cell surface glycans (aberrant sugar moieties found on colorectal cancer cells)
- Potential use in photodynamic chemotherapy
- Targeted therapy applications
Importantly, jacalin binds to IgA1 - a property also studied in kidney disease (IgA nephropathy) - showing the lectin has broad biological activity.
2. Artocarpin (Wood Extract)
A
2021 study in Scientific Reports tested a refined artocarpin-rich extract from jackfruit wood on human colorectal cancer cells (HCT116) and an animal model. Key findings:
- Inhibited CYP2C9, an enzyme overexpressed in colorectal cancer (CRC) models - IC50 of 0.46 µg/mL
- Cytotoxic to HCT116 colon cancer cells - IC50 of 4.23 mg/L at 72 hours
- In an azoxymethane/DSS colitis-induced mouse model (a standard CRC model), it suppressed tumour multiplicity and reduced expression of PCNA (a proliferation marker)
- Reduced pro-inflammatory cytokines (IL-6, IFN-γ) and pro-tumorigenic markers (VEGF, MYC, AXIN2)
- No observed toxicity at therapeutic doses
This is one of the strongest pieces of evidence - it combines in vitro and in vivo data showing genuine anti-colorectal cancer effects.
3. Other Phytochemicals
Jackfruit contains a range of compounds with established anti-cancer properties:
| Compound | Type | Activity |
|---|
| Artocarpin | Prenylated flavone | Anti-proliferative, CYP2C9 inhibitor |
| Jacalin | Lectin | Anti-colon cancer, targets glycans |
| Morin | Flavonoid | Antioxidant, anti-proliferative |
| Quercetin | Flavonoid | Apoptosis induction, anti-colorectal |
| Catechins | Polyphenol | Free-radical scavenging |
| β-carotene | Carotenoid | Antioxidant |
| Dietary fiber | Prebiotic | Gut microbiome modulation |
A 2022 review in
Current Pharmaceutical Design (
PMID 35652402) reviewed Indian fruits including jackfruit and summarised evidence for antiproliferative and immunomodulatory effects relevant to cancer prevention.
The Dietary Fiber - Gut Cancer Connection
Beyond specific phytochemicals, jackfruit is a good source of dietary fiber. This is relevant because:
- Fiber increases stool bulk, reducing contact time of carcinogens with colonic mucosa
- Fiber fermentation by gut bacteria produces short-chain fatty acids (SCFAs), especially butyrate, which promotes colonocyte health and has anti-tumour properties
- Higher fruit intake is associated with lower colorectal cancer (CRC) risk in a meta-analysis of observational studies (PMC10198059) - though this is not jackfruit-specific
Important Caveats
- All direct jackfruit studies are preclinical (cell lines and animal models). No human clinical trials or epidemiological studies specifically on jackfruit and CRC exist yet.
- The artocarpin studies used wood extract, not the edible fruit pulp - concentrations used may not be achievable through normal dietary intake.
- Jacalin is found in seeds, which are often discarded or not eaten raw - they require cooking, which may alter lectin activity.
- A 2022 review explicitly calls for translational and clinical studies to move this from bench to bedside.
Bottom Line
Jackfruit - particularly its seeds and wood extracts - contains compounds with demonstrable anti-colorectal cancer activity in lab and animal models. The most promising are jacalin (anti-colon cancer lectin) and artocarpin (reduces tumour growth and inflammation in colitis-associated CRC models). As a food, it also contributes fiber and antioxidant phytonutrients associated with lower GI cancer risk generally. However, no human trials exist yet, so clinical recommendations cannot be made beyond advising it as part of a healthy, plant-rich diet.